Chatzikalil E, Arvanitakis K, Kalopitas G, Florentin M, Germanidis G, Koufakis T
Cancers (Basel). 2025; 17(3).
PMID: 39941760
PMC: 11815926.
DOI: 10.3390/cancers17030392.
Li F, Li S, Shi Y, Lin F, Rui L, Shi J
Mediators Inflamm. 2024; 2024:4482642.
PMID: 39403548
PMC: 11473174.
DOI: 10.1155/2024/4482642.
Li T, Song Y, Wei L, Song X, Duan R
Cell Commun Signal. 2024; 22(1):491.
PMID: 39394612
PMC: 11470700.
DOI: 10.1186/s12964-024-01871-9.
Liu N, Liu G, Li Q, Hu Y, Wang H
Toxics. 2024; 12(9).
PMID: 39330572
PMC: 11436165.
DOI: 10.3390/toxics12090644.
Liu N, Liu S, Zhang X, Tian W, Jia H, Ye X
Oncol Lett. 2024; 28(5):529.
PMID: 39290957
PMC: 11406577.
DOI: 10.3892/ol.2024.14662.
Mechanism of ferroptosis regulating ischemic stroke and pharmacologically inhibiting ferroptosis in treatment of ischemic stroke.
Chai Z, Zheng J, Shen J
CNS Neurosci Ther. 2024; 30(7):e14865.
PMID: 39042604
PMC: 11265528.
DOI: 10.1111/cns.14865.
Prognostic and therapeutic model based on disulfidptosis-related genes for patients with clear cell renal cell carcinoma.
Xin S, Su J, Li R, Cao Q, Wang H, Wei Z
Heliyon. 2024; 10(11):e32258.
PMID: 38882384
PMC: 11180324.
DOI: 10.1016/j.heliyon.2024.e32258.
A novel MYC-ZNF706-SLC7A11 regulatory circuit contributes to cancer progression and redox balance in human hepatocellular carcinoma.
Chu J, Jiang J, Fan X, Liu J, Gao K, Jiang Y
Cell Death Differ. 2024; 31(10):1333-1348.
PMID: 38862581
PMC: 11445280.
DOI: 10.1038/s41418-024-01324-3.
SLC7A11 in hepatocellular carcinoma: potential mechanisms, regulation, and clinical significance.
Li T, Yi J, Wu H, Wang K, Zhou B
Am J Cancer Res. 2024; 14(5):2326-2342.
PMID: 38859833
PMC: 11162675.
DOI: 10.62347/KGCL7357.
Transcriptome analysis of Burkitt lymphoma cells treated with anti-convulsant drugs that are inhibitors of Epstein-Barr virus lytic reactivation.
Gorres K, Reineke D, Miller G
PLoS One. 2024; 19(4):e0299198.
PMID: 38635661
PMC: 11025866.
DOI: 10.1371/journal.pone.0299198.
METTL9-SLC7A11 axis promotes hepatocellular carcinoma progression through ferroptosis inhibition.
Bi F, Qiu Y, Wu Z, Liu S, Zuo D, Huang Z
Cell Death Discov. 2023; 9(1):428.
PMID: 38017014
PMC: 10684523.
DOI: 10.1038/s41420-023-01723-4.
Establishment of SLC7A11-knockout mouse and its preliminary investigation in melanoma.
Chen Y, Lu T, Liu Y, Liu Y, Bai S, Chen Q
In Vitro Cell Dev Biol Anim. 2023; 59(9):729-737.
PMID: 37932516
DOI: 10.1007/s11626-023-00819-6.
Mechanism of Cell Death by Combined Treatment with an xCT Inhibitor and Paclitaxel: An Alternative Therapeutic Strategy for Patients with Ovarian Clear Cell Carcinoma.
Idei U, Ohta T, Yamatani H, Seino M, Nagase S
Int J Mol Sci. 2023; 24(14).
PMID: 37511540
PMC: 10380372.
DOI: 10.3390/ijms241411781.
Identification and characterization of a novel molecular classification based on disulfidptosis-related genes to predict prognosis and immunotherapy efficacy in hepatocellular carcinoma.
Yang L, Zhang W, Yan Y
Aging (Albany NY). 2023; 15(13):6135-6151.
PMID: 37399661
PMC: 10373967.
DOI: 10.18632/aging.204809.
Nature-Inspired Bioactive Compounds: A Promising Approach for Ferroptosis-Linked Human Diseases?.
El Hajj S, Canabady-Rochelle L, Gaucher C
Molecules. 2023; 28(6).
PMID: 36985608
PMC: 10059971.
DOI: 10.3390/molecules28062636.
HPV16 E6 and E7 Oncoproteins Stimulate the Glutamine Pathway Maintaining Cell Proliferation in a SNAT1-Dependent Fashion.
Ortiz-Pedraza Y, Munoz-Bello J, Ramos-Chavez L, Martinez-Ramirez I, Olmedo-Nieva L, Manzo-Merino J
Viruses. 2023; 15(2).
PMID: 36851539
PMC: 9964736.
DOI: 10.3390/v15020324.
Nutrient transporters: connecting cancer metabolism to therapeutic opportunities.
Nwosu Z, Song M, Pasca di Magliano M, Lyssiotis C, Kim S
Oncogene. 2023; 42(10):711-724.
PMID: 36739364
PMC: 10266237.
DOI: 10.1038/s41388-023-02593-x.
Structural investigation of human cystine/glutamate antiporter system x (Sx ) using homology modeling and molecular dynamics.
Hang T, Hung H, Beckers P, Desmet N, Lamrani M, Massie A
Front Mol Biosci. 2022; 9:1064199.
PMID: 36533083
PMC: 9751330.
DOI: 10.3389/fmolb.2022.1064199.
Glutamatergic system components as potential biomarkers and therapeutic targets in cancer in non-neural organs.
Garcia-Gaytan A, Hernandez-Abrego A, Diaz-Munoz M, Mendez I
Front Endocrinol (Lausanne). 2022; 13:1029210.
PMID: 36457557
PMC: 9705578.
DOI: 10.3389/fendo.2022.1029210.
Immunotherapy against the Cystine/Glutamate Antiporter xCT Improves the Efficacy of APR-246 in Preclinical Breast Cancer Models.
Barutello G, Di Lorenzo A, Gasparetto A, Galiazzi C, Bolli E, Conti L
Biomedicines. 2022; 10(11).
PMID: 36359363
PMC: 9688020.
DOI: 10.3390/biomedicines10112843.